IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Alkermes PLC (ALKS)

CUSIP: G01767905 | Healthcare · Drug Manufacturers - Specialty & Generic | Mid Cap | 12 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile